Mon, Sep 22, 2014, 12:32 PM EDT - U.S. Markets close in 3 hrs 28 mins

Recent

% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • opinionscincy opinionscincy Mar 21, 2013 5:39 PM Flag

    ACAD Assigned New " Breakthrough" Designation, Allows Accelerated Approval. LINKED

    Yahoo News Type in Article Name in Google
    Article :FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing
    Five Star Equities Provides Stock Research on ACADIA Pharmaceuticals and BioCryst Pharmaceuticals
    The FDA's new "breakthrough" product designation allows new drugs to win approval after just a single round of testing, instead of the usual three. A total of three promising experimental medicines have been assigned the new status so far, while an additional 18 drugs have applied. The new designation follows three other programs -- Fast Track, Priority Review and Accelerated Approval -- each of which were designed to help bring crucial new drugs to market in a shorter amount of time.
    "A breakthrough drug is one that may offer important new benefits for patients with serious or life-threatening disease who are especially in need of new safe and effective treatments," said Janet Woodcock, director of FDA's Center for Drug Evaluation and Research.
    Five Star Equities releases regular market updates on the Biotechnology Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns
    ACADIA is a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has a pipeline of productcandidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson's disease psychosis.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACAD
25.89-0.75(-2.80%)12:31 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.